Are you expecting sales momentum from H2 FY18. If so, the result is not as bad as first thought. Maybe we could be as high as: $162m revenue $69m gross profit (based on 42.5% GP margin) $65m gross profit (assuming a further $4m provision and an overall $10m stock write off) $37m EBITDA (assumes similar expenses to H2) $26m NPAT
If this was achieved expect a major spike come 27 Feb. This would show increasing normalised NPAT for 3 quarters straight.
BAL Price at posting:
$8.06 Sentiment: Sell Disclosure: Held